Gilead Sciences Announces Second Quarter 2021 Dividend
Gilead Sciences, Inc. (Nasdaq: GILD) has announced a cash dividend of $0.71 per share for Q2 2021. This dividend is set to be paid on June 29, 2021, to shareholders recorded by the close of business on June 15, 2021. The company emphasizes that any future dividends will require Board approval. Gilead continues its commitment to developing innovative treatments for serious diseases globally.
- Declared a quarterly dividend of $0.71 per share, reflecting confidence in financial stability.
- Future dividends are contingent on Board approval, which may introduce uncertainty.
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared a cash dividend of
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
For more information on Gilead, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210429005960/en/
FAQ
What is the dividend amount declared by Gilead Sciences for Q2 2021?
When will Gilead Sciences pay its dividend?
Who is eligible to receive the Gilead Sciences dividend?
Will Gilead Sciences continue paying dividends in the future?
